Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Skeletal Radiology
|
January 1, 1997
Magnetic resonance imaging features of chloroma of the shoulder
N Gómez, E Ocón, A Friera, et al.
Revista Espanola De Enfermedades Digestivas
|
October 24, 2008
[Jejunal mucormycosis in a patient with Hodgkin's lymphoma]
B Madrigal, J J Arenal, A Torres, et al.
American Journal of Hematology
|
July 1, 1995
Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha
M J Peñarrubia, J L Steegmann, E Lavilla, et al.
Journal of Thrombosis and Thrombolysis
|
September 30, 2006
Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages
A Cantalapiedra, O Gutierrez, J I Tortosa, et al.
American Journal of Hematology
|
November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)
J L Steegmann, M J Requena, L F Casado, et al.
Sangre
|
December 30, 1998
[Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2]
J L Steegmann, E Granados, L Vázquez, et al.
Sangre
|
June 1, 1994
[Early bacterial infections in 103 patients treated with bone marrow transplantation]
J F Tomás, L M Hernández, M J Peñarrubia, et al.
Medicina Clinica
|
November 11, 1995
[Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients]
J F Tomás, M J Peñarrubia, J A García, et al.
Revista Clinica Espanola
|
August 1, 1996
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes]
A Figuera, J F Tomás, L Hernández, et al.
Annals of Hematology
|
October 1, 2003
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses
M J Peñarrubia, J Odriozola, C González, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Skeletal Radiology
|
January 1, 1997
Magnetic resonance imaging features of chloroma of the shoulder
N Gómez, E Ocón, A Friera, et al.
Revista Espanola De Enfermedades Digestivas
|
October 24, 2008
[Jejunal mucormycosis in a patient with Hodgkin's lymphoma]
B Madrigal, J J Arenal, A Torres, et al.
American Journal of Hematology
|
July 1, 1995
Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha
M J Peñarrubia, J L Steegmann, E Lavilla, et al.
Journal of Thrombosis and Thrombolysis
|
September 30, 2006
Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages
A Cantalapiedra, O Gutierrez, J I Tortosa, et al.
American Journal of Hematology
|
November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)
J L Steegmann, M J Requena, L F Casado, et al.
Sangre
|
December 30, 1998
[Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2]
J L Steegmann, E Granados, L Vázquez, et al.
Sangre
|
June 1, 1994
[Early bacterial infections in 103 patients treated with bone marrow transplantation]
J F Tomás, L M Hernández, M J Peñarrubia, et al.
Medicina Clinica
|
November 11, 1995
[Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients]
J F Tomás, M J Peñarrubia, J A García, et al.
Revista Clinica Espanola
|
August 1, 1996
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes]
A Figuera, J F Tomás, L Hernández, et al.
Annals of Hematology
|
October 1, 2003
A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses
M J Peñarrubia, J Odriozola, C González, et al.
Page
of 2